ALTUM SEQUENCING, S.L.

Altum Sequencing S.L. is a Spanish biotechnology company specialized in precision oncology, advanced genomic sequencing and liquid biopsy. The company develops and provides innovative solutions for tumor molecular profiling and ultra-sensitive monitoring of measurable residual disease using next-generation sequencing, circulating tumor DNA analysis and advanced bioinformatics tools.

Its activity is focused on supporting healthcare professionals, hospitals, research institutions and pharmaceutical companies in understanding cancer molecular evolution, assessing treatment response, detecting relapse at an early stage and supporting the clinical development of new oncology therapies. Altum Sequencing is particularly focused on longitudinal cancer monitoring, integrating genomic, clinical and analytical data to provide actionable information for medical decision-making and clinical trial design.

The company has developed proprietary technologies aimed at detecting and quantifying patient-specific tumor markers, with applications in both hematological malignancies and solid tumors. Its solutions enable dynamic disease monitoring through blood samples, contributing to more personalized, predictive and minimally invasive oncology care.